Vivian Wu | Director, Investor Relations and Corporate Affairs |
Howard Robin | President and Chief Executive Officer |
Brian Kotzin | Chief Medical Officer |
Jonathan Zalevsky | Chief Research and Development Officer |
Jillian Thomsen | Chief Financial Officer |
Chris Shibutani | Goldman Sachs |
Roger Song | Jefferies Group LLC |
Jessica Fye | JPMorgan Chase & Co. |
Greg Harrison | Bank of America Merrill Lynch |
Andy Hsieh | William Blair & Company |
Good day, and thank you for standing by. Welcome to the Nektar Therapeutics Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.